Status:

COMPLETED

A Real-world Study About the Impact of Adverse Events (AEs) on Treatment Adjustments, Healthcare Resource Use, and Costs Among Chronic Myeloid Leukemia Patients

Lead Sponsor:

Novartis Pharmaceuticals

Conditions:

Leukemia, Chronic Myeloid

Eligibility:

All Genders

18+ years

Brief Summary

The aim of this study was to assess the frequency of adverse events (AEs) experienced by chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors (TKIs) and evaluate their impac...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Patients who met all of the following criteria were considered for inclusion:
  • Had at least two diagnoses for CML- International Classification of Disease, 10th revision, Clinical Modification (ICD-10-CM) code: C92.1x
  • Aged 18 years or older at the time of first CML diagnosis
  • Received a 1G or 2G TKI after the first CML diagnosis
  • Had continuous health plan enrollment (pharmacy and medical benefits) for at least 6 months before the index date (baseline) and 6 months after the index date
  • Exclusion criteria:
  • Patients who met any of the following criteria were excluded:
  • Patients had 2 or more diagnoses of gastrointestinal stromal tumor (\[GIST\], ICD-10: C49.Ax) or chronic myelomonocytic leukemia (\[CMML\], ICD-10: C93.1x) at any time
  • Patients had a hematopoietic stem cell transplantation (HSCT) during the baseline period
  • Patients had CML-related chemotherapy treatment for accelerated phase (AP)/blast crisis (BC) during the baseline period
  • Patients had medical claims associated with a clinical trial during the baseline period up to the end of the observation period

Exclusion

    Key Trial Info

    Start Date :

    April 8 2024

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    October 22 2024

    Estimated Enrollment :

    2546 Patients enrolled

    Trial Details

    Trial ID

    NCT07151820

    Start Date

    April 8 2024

    End Date

    October 22 2024

    Last Update

    September 3 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Novartis

    East Hanover, New Jersey, United States, 07936

    A Real-world Study About the Impact of Adverse Events (AEs) on Treatment Adjustments, Healthcare Resource Use, and Costs Among Chronic Myeloid Leukemia Patients | DecenTrialz